Cargando…
Intraamygdaloid Oxytocin Reduces Anxiety in the Valproate-Induced Autism Rat Model
Background: Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder affecting about 1.5% of children, and its prevalence is increasing. Anxiety is one of the most common comorbid signs of ASD. Despite the increasing prevalence, the pathophysiology of ASD is still poorly understood,...
Autores principales: | László, Kristóf, Kiss, Orsolya, Vörös, Dávid, Mintál, Kitti, Ollmann, Tamás, Péczely, László, Kovács, Anita, Zagoracz, Olga, Kertes, Erika, Kállai, Veronika, László, Bettina, Hormay, Edina, Berta, Beáta, Tóth, Attila, Karádi, Zoltán, Lénárd, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962302/ https://www.ncbi.nlm.nih.gov/pubmed/35203614 http://dx.doi.org/10.3390/biomedicines10020405 |
Ejemplares similares
-
The Role of Intraamygdaloid Oxytocin and D2 Dopamine Receptors in Reinforcement in the Valproate-Induced Autism Rat Model
por: László, Kristóf, et al.
Publicado: (2022) -
Intraamygdaloid Oxytocin Increases Time Spent on Social Interaction in Valproate-Induced Autism Animal Model
por: Vörös, Dávid, et al.
Publicado: (2023) -
Effect of D1- and D2-like Dopamine Receptor Antagonists on the Rewarding and Anxiolytic Effects of Neurotensin in the Ventral Pallidum
por: Ollmann, Tamás, et al.
Publicado: (2022) -
The antipsychotic drug sulpiride in the ventral pallidum paradoxically impairs learning and induces place preference
por: Dusa, Daniella, et al.
Publicado: (2022) -
Novel probiotic treatment of autism spectrum disorder associated social behavioral symptoms in two rodent models
por: Mintál, Kitti, et al.
Publicado: (2022)